Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Peter Mueller currently holds 17,000 shares of BioXcel Therapeutics, Inc. (BTAI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Peter Mueller has been a net seller of BTAI stock. They have purchased $152.9K and sold $33.3M worth of shares.
Peter Mueller's most recent insider trade was on Jan 9, 2026, when they sold 17,000 shares at $0.00 per share.
Peter Mueller serves as Executive at BioXcel Therapeutics, Inc. (BTAI). They have executed 207 insider transactions totaling $33.5M over their tenure at the company.
Peter Mueller holds the position of Executive at BioXcel Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
Peter Mueller has shown a selling trading pattern, with $152.9K in total purchases and $33.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Peter Mueller was on Jan 15, 2014, when they sold $590.0K worth of VRTX shares. This transaction involved 7,500 shares at $78.67 per share.
Peter Mueller currently owns 17,000 shares of BioXcel Therapeutics, Inc. (BTAI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Peter Mueller's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Peter Mueller has 207 Form 4 filings on record as an insider at BioXcel Therapeutics, Inc..
Set alerts for Peter Mueller and 40,000+ other insiders.